Nav 1.6 channel modulator (Howard Florey Institute)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameNav 1.6 channel modulator (Howard Florey Institute)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel protein type VIII alpha subunit modulators
TargetsSodium channel protein type VIII alpha subunit
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHoward Florey Institute of Experimental Physiology and Medicine
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHoward Florey Institute of Experimental Physiology and Medicine
Active IndicationsN/A
Inactive IndicationsMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A